Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haochang Hu

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Bioactive Materials|February 23, 2024
Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosisLan Xie, Jinyong Chen, Haochang Hu, et al.
Biomed Research International|June 15, 2019
Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation Meta-AnalysisXiaofeng Xu, Haochang Hu, Ying Lin, et al.
Oncology Letters|May 29, 2018
Hypermethylation of <i>MDFI</i> promoter with NSCLC is specific for females, non-smokers and people younger than 65Hongying Ma, Xiaoying Chen, Haochang Hu, et al.
Bosnian Journal of Basic Medical Sciences|September 21, 2019
A male-specific association between AGTR1 hypermethylation and coronary heart diseaseXiaojing Li, Nan Wu, Huihui Ji, et al.
Pathology Oncology Research : POR|October 29, 2018
Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal CancerHaochang Hu, Tiangong Wang, Ranran Pan, et al.
Pathology, Research and Practice|August 8, 2018
Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysisHaochang Hu, Cong Zhou, Bin Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 23, 2017
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinomaXiaoying Chen, Haochang Hu, Jing Liu, et al.
Neuroscience Letters|November 14, 2016
Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populationsGuili Liu, Huihui Ji, Jing Liu, et al.
Future Oncology (London, England)|July 5, 2018
SMYD3 promoter hypomethylation is associated with the risk of colorectal cancerBin Li, Ranran Pan, Cong Zhou, et al.
Peerj|September 19, 2018
Cong Zhou, Ranran Pan, Haochang Hu, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Bioactive Materials|February 23, 2024
Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosisLan Xie, Jinyong Chen, Haochang Hu, et al.
Biomed Research International|June 15, 2019
Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation Meta-AnalysisXiaofeng Xu, Haochang Hu, Ying Lin, et al.
Oncology Letters|May 29, 2018
Hypermethylation of <i>MDFI</i> promoter with NSCLC is specific for females, non-smokers and people younger than 65Hongying Ma, Xiaoying Chen, Haochang Hu, et al.
Bosnian Journal of Basic Medical Sciences|September 21, 2019
A male-specific association between AGTR1 hypermethylation and coronary heart diseaseXiaojing Li, Nan Wu, Huihui Ji, et al.
Pathology Oncology Research : POR|October 29, 2018
Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal CancerHaochang Hu, Tiangong Wang, Ranran Pan, et al.
Pathology, Research and Practice|August 8, 2018
Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysisHaochang Hu, Cong Zhou, Bin Li, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 23, 2017
FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinomaXiaoying Chen, Haochang Hu, Jing Liu, et al.
Neuroscience Letters|November 14, 2016
Association of OPRK1 and OPRM1 methylation with mild cognitive impairment in Xinjiang Han and Uygur populationsGuili Liu, Huihui Ji, Jing Liu, et al.
Future Oncology (London, England)|July 5, 2018
SMYD3 promoter hypomethylation is associated with the risk of colorectal cancerBin Li, Ranran Pan, Cong Zhou, et al.
Peerj|September 19, 2018
Cong Zhou, Ranran Pan, Haochang Hu, et al.
Pageof 5